LexDanaLexDanabeta
Inventor

Xirui HU

Inventor
US

Overview

3→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,161,648Covalent targeting of E3 ligases202412,110,290Triazolopyridinyl compounds as kinase inhibitors202411,767,322Triazolopyridinyl compounds as kinase inhibitors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to NOVARTIS AG (1)· patent assignee history
2024Patents assigned to UNIV CALIFORNIA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO22023–2024
NOVARTIS AG12024
UNIV CALIFORNIA12024
Locations
LocationPatentsSpan
US32023–2024